Previous Article | Next Article ![]()
Journal of Clinical Microbiology, December 2001, p. 4349-4356, Vol. 39, No. 12
Institut de Bactériologie de la
Faculté de Médecine de Strasbourg
Received 8 May 2001/Returned for modification 1 July 2001/Accepted 8 September 2001
Clinical symptoms of impetigo and staphylococcal scalded skin
syndrome may not only be expressed as the splitting of cell layers
within the epidermis but are often accompanied by some localized
inflammation. Toxin patterns of Staphylococcus aureus isolates originating from patients with impetigo and also from those
with other primary and secondary skin infections in a retrospective isolate collection in France and a prospective isolate collection in
French Guiana revealed a significant association (75% of the cases
studied) of impetigo with production of at least one of the
epidermolysins A and B and the bicomponent leucotoxin LukE-LukD (P < 0.001). However, most of the isolates were
able to produce one of the nonubiquitous enterotoxins. Pulsed-field gel
electrophoresis (PFGE) of genomic DNA hydrolyzed with
SmaI showed a polymorphism of the two groups of isolates
despite the fact that endemic clones were suspected in French Guiana
and France. The combination of toxin patterns with PFGE fingerprinting
may provide further discrimination among isolates defined in a given
cluster or a given pulsotype and account for a specific virulence. The
new association of toxins with a clinical syndrome may reveal
principles of the pathological process.
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.12.4349-4356.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Staphylococcus aureus Isolated in
Cases of Impetigo Produces Both Epidermolysin A or B and
LukE-LukD in 78% of 131 Retrospective and Prospective
Cases
Hôpitaux
Universitaires de Strasbourg,1 and
Institut d'Hygiène de la Faculté de Médecine
de Strasbourg
Hôpitaux Universitaires de
Strasbourg,3 F-67000 Strasbourg, and
Institut Guyanais de Dermatologie Tropicale, Service de
Dermatologie,2 and Laboratoire de
Bactériologie,4 C.H.G. de Cayenne, 97306 Cayenne Cedex, France
*
Corresponding author. Mailing address: Institut de
Bactériologie de la Faculté de Médecine de
Strasbourg
Hôpitaux Universitaires de Strasbourg 3, rue
Koeberlé, F-67000 Strasbourg, France. Phone: 33 3 90 24 37 57. Fax: 33 3 88 25 11 13. E-mail:
gilles.prevost{at}medecine.u-strasbg.fr.
This article has been cited by other articles:
| Antimicrob. Agents Chemother. | Clin. Microbiol. Rev. |
|---|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|